Table 1.
Demographic, baseline clinical characteristics, and CMR parameters of the patients enrolled
| All myocarditis (n = 113) | |||
|---|---|---|---|
| Septal LGE (n = 31) |
Infero-lateral LGE (n = 82) |
p | |
| Age, years | 56.92 ± 18.89 | 34.63 ± 15.68 | 0.002 |
| Male, n (%) | 17 (55%) | 72 (87%) | 0.001 |
| Weight, kg | 69.22 ± 14.59 | 71.65 ± 12.41 | 0.516 |
| Height, cm | 168.40 ± 6.18 | 172.07 ± 5.57 | 0.028 |
| BSA, m2 | 1.77 ± 0.19 | 1.83 ± 0.16 | 0.232 |
| Hypertension, n (%) | 8 (25%) | 12 (15%) | 0.004 |
| Dyslipidemia, n (%) | 4 (13%) | 8 (10%) | 0.017 |
| Obesity, n (%) | 9 (29%) | 4 (5%) | 0.777 |
| Smoke, n (%) | 10 (32%) | 6 (7%) | 0.380 |
| Diabetes, n (%) | 1 (3%) | 4 (5%) | 0.070 |
| Familiarity for CAD, n (%) | 5 (16%) | 14 (17%) | 0.225 |
| LVEF, % | 49.09 ± 12.03 | 56.18 ± 8.34 | 0.009 |
| LVEDV/BSA, ml/m2 | 97.28 ± 34.05 | 93.57 ± 21.05 | 0.522 |
| LVESV/BSA, ml/m2 | 51.69 ± 31.42 | 43.61 ± 19.06 | 0.129 |
| LVSV/BSA, ml/m2 | 46.68 ± 9.77 | 51.14 ± 9.27 | 0.056 |
| LV mass/BSA, g/m2 | 62.31 ± 17.57 | 61.10 ± 11.07 | 0.693 |
| Reservoir, % | 25.41 ± 10.99 | 34.42 ± 11.53 | 0.001 |
| Reservoir rate, s−1 | 1.61 ± 2.40 | 1.56 ± 0.55 | 0.871 |
| Conduit, % | 12.17 ± 8.02 | 20.98 ± 9.13 | 0.001 |
| Conduit rate, s−1 | − 1.28 ± 0.94 | − 2.23 ± 0.92 | 0.001 |
| Booster, % | 12.89 ± 5 | 13.39 ± 4.92 | 0.637 |
| Booster rate, s−1 | − 1.52 ± 0.62 | − 1.52 ± 0.62 | 0.086 |
| LA volume | 11.98 ± 2.16 | 11.67 ± 2.16 | 0.719 |
LA volume was indexed to body surface area. Bold indicates statistical significance
BSA body surface area, CAD coronary artery disease, LA left atrium, LGE late gadolinium enhancement, LVEF left ventricle ejection fraction, LVEDV left ventricle end-diastolic volume, LVESV left ventricle end-systolic volume, LVSV left volume stroke volume